Ketorolac S.A.L.F.

Ketorolac, the active ingredient in Ketorolac S.A.L.F., is a nonsteroidal anti-inflammatory drug presented as an injectable solution for intramuscular and intravenous use. It treats moderate to severe acute pain, particularly post‑operative pain, in adult patients.\n\nGNH India supplies Ketorolac S.A.L.F. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement teams worldwide, ensuring quality, reliable logistics and full regulatory documentation for global distribution.

Ketorolac is a nonsteroidal anti‑inflammatory drug used to manage pain by inhibiting prostaglandin synthesis.\n\n- Acute moderate to severe pain: provides rapid analgesia for up to five days.\n- Post‑operative pain: reduces pain intensity after surgical procedures.\n- Short‑term management of severe acute pain: offers effective relief when opioid therapy is not preferred.

Ketorolac may cause a range of adverse reactions, varying from mild to severe.\n\nCommon Side Effects:\n- Nausea: mild to moderate upset stomach.\n- Headache: transient cranial discomfort.\n- Dizziness: occasional light‑headed feeling.\n- Injection‑site pain: local soreness or irritation.\n- Gastrointestinal discomfort: dyspepsia or abdominal pain.\n- Vomiting: occasional emesis.\n- Diarrhea: loose stools.\n\nSerious or Rare Side Effects:\n- Gastrointestinal bleeding: potentially life‑threatening hemorrhage.\n- Renal impairment: reduced kidney function, especially with prolonged use.\n- Severe allergic reactions: anaphylaxis, angioedema, or skin rash.\n- Cardiovascular events: myocardial infarction or stroke risk.\n- Liver enzyme elevation: abnormal hepatic function tests.

When using ketorolac, clinicians should consider several safety precautions to minimize risk.\n\n- Renal function: assess baseline kidney status and avoid in severe impairment.\n- Bleeding risk: contraindicated in active gastrointestinal ulcer or coagulopathy.\n- Cardiovascular disease: use cautiously in patients with heart disease history.\n- Pregnancy and lactation: avoid unless benefits clearly outweigh potential risks.\n- Concomitant NSAIDs: limit combined use to reduce additive toxicity.\n- Store at ambient temperature: keep in original container, protect from light and moisture.

Ketorolac can interact with several medicines, altering its safety or effectiveness.\n\nMajor Interactions (Avoid):\n- Anticoagulants (e.g., warfarin, heparin): increased risk of serious bleeding.\n- Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity.\n\nModerate Interactions (Monitor Closely):\n- ACE inhibitors or diuretics: may reduce renal function; monitor creatinine.\n- Lithium: NSAIDs can raise lithium levels; monitor serum.\n- Methotrexate: reduced clearance may cause toxicity; adjust dose if needed.